Commercial Manufacturing
Through the recently announced state-of-the-art facility addition, SurModics is significantly expanding its manufacturing capability. In April 2008
(see press release), SurModics announced purchase of an additional facility for development and manufacturing capacity in Birmingham, Alabama. “This is great news for Alabama”, said Governor of Alabama Bob Riley. The addition includes a total floor space of 286,000 sq ft. located on a 42- acre campus. About
151,000 sq. ft. manufacturing will be dedicated to development and manufacturing. This particular building was selected because it will accommodate the manufacturing of large-scale pharmaceutical products needed by SurModics’ customers.
Manufacturing space in SurModics’ new facility
Construction is underway at SurModics’ new facility and includes:
- 95,000 sq. ft. now under construction for commercial manufacturing
- 5 suites
– 3 processing (e.g., microencapsulation, extrusion, liposomes, nanoparticles)
– 2 solution preparation - Aseptic manufacturing, using isolation technology for both drug and medical device (e.g., 100-kg microparticle batches)
- Facilities available for manufacturing of products requiring terminal sterilization
- Microbiology laboratory for in-process and final product testing
- Quality Control laboratory for in-process and finished product
- All utilities to support aseptic manufacturing, including state of the art water for injection system (3000 gallons)
SurModics recently acquired 286,000 sq. ft. facility